Moricizine is a Class III antiarrhythmic agent within the phenothiazine derivative family, primarily indicated for the treatment of ventricular arrhythmias and the maintenance of a normal heart rate. This… Read more






Moricizine is a Class III antiarrhythmic agent within the phenothiazine derivative family, primarily indicated for the treatment of ventricular arrhythmias and the maintenance of a normal heart rate. This category provides essential pharmaceutical reference standards required for rigorous analytical testing and quality control of this active pharmaceutical ingredient. Laboratories rely on these high-quality compounds, including synthetic impurities and degradation products, to facilitate accurate impurity profiling and to support the development and validation of analytical methods. Additionally, the inclusion of stable isotope labelled compounds, such as deuterated moricizine, provides critical internal standards for mass spectrometry-based assays, enabling precise metabolic profiling and quantitative analysis in complex biological matrices. Utilizing these standardized materials ensures regulatory compliance and verifies the consistency of the drug substance throughout the manufacturing and testing lifecycle.